ã¡ãã£ã¢èšäº
次äžä»£ã¯ã¯ãã³æ²»éšéå§ãçæéã§å€§éäŸçµŠå¯èœã22幎å®çšåç®æš
ããºãææ°ããŒã¯ 98
twitterã³ã¡ã³ã 78ä»¶äž 1ïœ78件
絶察ã«ãããªãïŒäœå
ã§å¢æ®ãããšãããŠã€ã«ã¹ããã
æäžåŸã«äœå
ã§èªå·±å¢æ®ãããã¬ããªã³ã³ããšåŒã°ããæ°æè¡ãçšãã ã¯ã¯ãã³ã®åæ段éã®æ²»éšïŒç¬¬ïŒçžæ²»éšãéå§ãããšåµè¬ãã³ãã£ãŒãïŒïŒæ¥çºè¡šããŸãããçæéã§å€§éäŸçµŠãå¯èœãšãããæ¥å¹Žäžã®å®çšåãããããŠããŸãã
æ°ãã«èªå·±å¢æ®åã¯ã¯ãã³ãåºãŸãðð©ž
æäžéãå°ãªããã°å¯äœçšãå°ãªããäžå®æéã«å
šåœæ°ã察å¿ããªããšç¡ããªããªãããïŒ
ã§ãããšãããææŠããã°ãããšæããŸããããã§ç€ŸäŒããããªã£ãŠããã®ãªãã
èŠçŽããã¶ãŒïŒ
åµè¬ãã³ãã£ãŒã®vlpã»ã©ãã¥ãŒãã£ã¯ã¹ã»ãžã£ãã³ã¯18æ¥ãæ°åã³ãããŠã€ã«ã¹ã¯ã¯ãã³ã®å®çšåãç®æããšçºè¡šãããã²ãã æ å ±ãäŒããrnaãäœå ã§èªå·±å¢æ®ããå¹ççã«å ç«ãèªå°ãããæäžéãçŸåšã®mrnaã¯ã¯ãã³ã®10åã®1ãã100åã®1ã«æžããšããã
åµè¬ãã³ãã£ãŒã®vlpã»ã©ãã¥ãŒãã£ã¯ã¹ã»ãžã£ãã³ã¯18æ¥ãæ°åã³ãããŠã€ã«ã¹ã¯ã¯ãã³ã®å®çšåãç®æããšçºè¡šãããã²ãã æ å ±ãäŒããrnaãäœå ã§èªå·±å¢æ®ããå¹ççã«å ç«ãèªå°ãããæäžéãçŸåšã®mrnaã¯ã¯ãã³ã®10åã®1ãã100åã®1ã«æžããšããã
VLPã»ã©ãã¥ãŒãã£ã¯ã¹ã»ãžã£ãã³
æ©ãæ©ãã ã
æ¥å¹Žäžã«å®çšåãž
ã©ãããªãæ¥çš®ãã人ã®äœå
ã§å¢æ®ããŠãã¯ã¯ãã³ãŠã€ã«ã¹äœã£ãŠããããäœå€ã«æãæ£ãããŠä»äººã«ææãããŠã¯ã¯ãã³æããªããŠæžããããªã¯ã¯ãã³ãŠã€ã«ã¹ã¿ãããªã®åºæ¥ããè¯ãã®ã«ãã次ã
å¢æ®ããŠææãããã®ã§ç¹å®ã®äººã ãæãŠã°åæã«åºããã¿ãããªã
ãããå¹ãç®ãå¯åå¿ã®åŒ·åŒ±ã®ã°ãã€ãã倧ããããªå°è±¡ããããæå°ã§ãæ¥æ¬è£œã®ã¯ã¯ãã³ãæã¡ãã人ã«ã¯è¯ãè¬ããç¥ããªããã
èªåã§å¢ããRNAð°ãããªã«éœåè¯ãã³ã³ãããŒã«åºæ¥ãã®ãâçæéã®æ²»éšã§èš±å¯ãããâŠã¢ãã«ãã¿ããæ¥çš®ããåŸã§ã¯åãè¿ãã€ãããð°
çŸç©ã®æ²»éšäžã«æ¬¡äžä»£ã£ãŠé ã€ã«ã¬ãŠãð±ð±
çŸç©ã®æ²»éšäžã«æ¬¡äžä»£ã£ãŠé ã€ã«ã¬ãŠãð±ð±
ã¬ããªã³ã³ã¯ã¯ãã³ã¯åœå
ã§ã¯åããŠ
mRNAã¯ã¯ãã³ã®äžçš®ã ããã¡ã€ã¶ãŒç€Ÿè£œãªã©ãšç°ãªã现èå ã§äžå®æéã«éãèªå·±å¢æ®ããæ©èœãæãããŠããããå°éã®æäžã§ãå ç«åå¿ãèµ·ããããšãå¯èœ
mRNAã¯ã¯ãã³ã®äžçš®ã ããã¡ã€ã¶ãŒç€Ÿè£œãªã©ãšç°ãªã现èå ã§äžå®æéã«éãèªå·±å¢æ®ããæ©èœãæãããŠããããå°éã®æäžã§ãå ç«åå¿ãèµ·ããããšãå¯èœ
ãã¯ããã ã®ããžãã¹ãä»ãåã£ãŠããããŒðº
èŠçŽããã¶ãŒïŒ
åµè¬ãã³ãã£ãŒã®vlpã»ã©ãã¥ãŒãã£ã¯ã¹ã»ãžã£ãã³ã¯18æ¥ãæ°åã³ãããŠã€ã«ã¹ã¯ã¯ãã³ã®å®çšåãç®æããšçºè¡šãããã²ãã æ å ±ãäŒããrnaãäœå ã§èªå·±å¢æ®ããå¹ççã«å ç«ãèªå°ãããæäžéãçŸåšã®mrnaã¯ã¯ãã³ã®10åã®1ãã100åã®1ã«æžããšããã
åµè¬ãã³ãã£ãŒã®vlpã»ã©ãã¥ãŒãã£ã¯ã¹ã»ãžã£ãã³ã¯18æ¥ãæ°åã³ãããŠã€ã«ã¹ã¯ã¯ãã³ã®å®çšåãç®æããšçºè¡šãããã²ãã æ å ±ãäŒããrnaãäœå ã§èªå·±å¢æ®ããå¹ççã«å ç«ãèªå°ãããæäžéãçŸåšã®mrnaã¯ã¯ãã³ã®10åã®1ãã100åã®1ã«æžããšããã
æ²»éšåå è
éããã®å€§å€ãªã®ã§ã¯
ãŸãããçµ±åå»çä¿éºèšºçåããå
ã
ãã ããïŒïŒ
以äžïŒïŒ
ãã ããïŒïŒ
以äžïŒïŒ
ãæäžåŸã«äœå
ã§èªå·±å¢æ®ãããã¬ããªã³ã³ïŒæ¬¡äžä»£ã¡ãã»ã³ãžã£ãŒïŒmïŒRNAïŒããšåŒã°ããæ°æè¡ããmRNAã¯ã¯ãã³ãšæ¯ã¹ãŠæäžéã10åã®1ïœ100åã®1ã§æžã¿ãçæéã§å€§éäŸçµŠãå¯èœãâ
åµè¬ãã³ãã£ãŒã®VLPã»ã©ãã¥ãŒãã£ã¯ã¹ã»ãžã£ãã³ïŒæ±äº¬ïŒã¯18æ¥ãéçºãé²ããŠãã次äžä»£åã®æ°åã³ãããŠã€ã«ã¹ã¯ã¯ãã³ã«ã€ããŠãæ¥å¹Žäžã®å®çšåãç®æããšçºè¡šããã
次äžä»£ã¯ã¯ãã³ããããŒãšäžç¬æã£ããã© $BNTX ãæåã«éžãã 4çš®é¡ã®åè£ã®äžã€ã¯self-amplifying mRNAã ã£ãããïŒ
ãã³ãã«made in Japanãªã®ããªð€
ãã³ãã«made in Japanãªã®ããªð€
åºæ¬çã«ã¯ã¯ã¯ãã³è¯å®æŽŸãªã®ã ããã¬ããªã³ã³ã¯ã¯ãã³ã¯æ
éã«å°å
¥ããªããšå±ãªãããšãïŒ
ã©ãé¿ãããïŒ
ïŒVLPã®ã¯ã¯ãã³ã¯ããŠã€ã«ã¹ã®éºäŒæ
å ±ãäŒããRNAãäœå
ã§èªå·±å¢æ®ããå¹ççã«å
ç«ãèªå°ãããã¬ããªã³ã³ã¯ã¯ãã³ããæäžéãçŸåšã®mRNAã¯ã¯ãã³ã®10åã®1ãã100åã®1ã§æžããšããã
äœå
ã§èªå·±å¢æ®âŠå°éã ããå®å¿ãšããããå°éã§ã10æ¥ãèªå·±å¢æ®ããæ¹ãã€ã¡ãŒãžæããã©éãã®ããªãâŠ
ãŠã€ã«ã¹ã®éºäŒæ
å ±ãäŒããRNAãäœå
ã§èªå·±å¢æ®ããå¹ççã«å
ç«ãèªå°ãããã¬ããªã³ã³ã¯ã¯ãã³ããæäžéãçŸåšã®mRNAã¯ã¯ãã³ã®10åã®1ãã100åã®1ã§æžããšããã
æ°æã¡æªãã
æ°æã¡æªãã
è³ééãã®è±ç«äžããã®ããªïŒ
åœã®æé·æŠç¥ãšããŠãŸãã¯ãããããšãããæè³ããŠæ¬²ããã
VLPã»ã©ãã¥ãŒãã£ã¯ã¹ã»ãžã£ãã³ïŒæ°åã³ãã次äžä»£ã¯ã¯ãã³ïŒã¬ããªã³ã³ã¯ã¯ãã³ïŒãæ¥å¹Žå®çšå
äœå ã§èªå·±å¢æ®ããRNAã¯ã¯ãã³ãªã®ã§ãmRNAã®10/1ãã100/1ã®æäžéã§æžããããããæªçšããããäœãã§ããããèããã ãã§ãæãããã
絶察ã«æã¡ãããªãã
äœå ã§èªå·±å¢æ®ããRNAã¯ã¯ãã³ãªã®ã§ãmRNAã®10/1ãã100/1ã®æäžéã§æžããããããæªçšããããäœãã§ããããèããã ãã§ãæãããã
絶察ã«æã¡ãããªãã
ãã¬ããããã¶ããã®
è¿äºãé¢çœã件
è¿äºãé¢çœã件
ã¬ããªã³ã³ã¯ã¯ãã³èšåºè©Šéšéå§ãå°éã§æžãã¿ãããåœç£ã ããå®å¿ãšãã£ãŠæ¥çš®ãã人ããã®ããªð€
ã¬ããªã³ã³ãð
ã¬ããªã³ã³ãð
次äžä»£ã¯ã¯ãã³ããã¹ãæ¬åœã®ç
ã¯ããã§ã¯ãããŸããã®ã§ãã¯ãã
â ïžäœå
èªå·±å¢æ®ããâ ïžåœå
å ã¬ããªã³ã³mRNAðæ²»éšéå§âŒïž
ðåµè¬ãã³ãã£ãŒãVLPã»ã©ãã¥ãŒãã£ã¯ã¹ã»ãžã£ãã³ã
第äžçžæ²»éšéå§
æäžé1/10ïœ1/100ã§çæéã§å€§éäŸçµŠå¯èœ
â22幎äžã®å®çšåç®æã
ãæ žé žðãã®äžçš®ã ããã¡ãã¶ãŒçãšç°ãªãã现èå ã§äžå®æéã«éãèªå·±å¢æ®
ðåµè¬ãã³ãã£ãŒãVLPã»ã©ãã¥ãŒãã£ã¯ã¹ã»ãžã£ãã³ã
第äžçžæ²»éšéå§
æäžé1/10ïœ1/100ã§çæéã§å€§éäŸçµŠå¯èœ
â22幎äžã®å®çšåç®æã
ãæ žé žðãã®äžçš®ã ããã¡ãã¶ãŒçãšç°ãªãã现èå ã§äžå®æéã«éãèªå·±å¢æ®
ã§ããé ã«ã¯çµãã£ãŠããããã
ïŒ
ïŒ
éãå°ãªãã ãããã¡ãªããã§ã¯ãªããšæããã©ãä»ã§ãéç£ã§ããŠãããä»ã®0.3mLæäžã§ãéã«ãã身äœãžã®è² è·ã¯ãŒãã§ããã
ã¯ã¯ãã³ãšç§°ãããã®ã¯çæéã§åºæ¥ãããã«ãªã£ãããã
æ°åã³ãããŠã€ã«ã¹ãããã®ãã©ãããŸã äžçã®èª°ã«ãããã£ãŠããªãã®ã«
æ°åã³ãããŠã€ã«ã¹ãããã®ãã©ãããŸã äžçã®èª°ã«ãããã£ãŠããªãã®ã«
æ²»éšæéã¯æçãã¡ããã¡ã ãð¡ä»ã®ðã®ç¹äŸæ¿èªã«ããã€ããŠãŸãå®å
šæ§ã®ç¢ºèªåºæ¥ãªããã®ããããã£ãŠåºããŠæ¥ããšã¯æ¬åœã«ææªã ã
ã¬ããªã³ã³ã¯ã¯ãã³
æ¥çš®åŸãŠã€ã«ã¹ã®éºäŒæ å ±ãäŒããRNAãäœå ã§èªå·±å¢æ®ãæéãçµã€ãšæ¶å€±ãããæäžéãçŸåšã®mRNAã¯ã¯ãã³ã®1/10ã»ã©ã§æžãâŠ
補é ã¯æã€ã³ãã«ãšã³ã¶è¬ã¢ãã¬ã³ã§æåãªå¯å£«ãã€ã«ã å¯å±±ååŠãšãã話ãã¬ã€ã¢ã®å€æãã§ã玹ä»ãããããã¬ãŒã¯ãããâŠ
æ¥çš®åŸãŠã€ã«ã¹ã®éºäŒæ å ±ãäŒããRNAãäœå ã§èªå·±å¢æ®ãæéãçµã€ãšæ¶å€±ãããæäžéãçŸåšã®mRNAã¯ã¯ãã³ã®1/10ã»ã©ã§æžãâŠ
補é ã¯æã€ã³ãã«ãšã³ã¶è¬ã¢ãã¬ã³ã§æåãªå¯å£«ãã€ã«ã å¯å±±ååŠãšãã話ãã¬ã€ã¢ã®å€æãã§ã玹ä»ãããããã¬ãŒã¯ãããâŠ
ä»åŸã¯ä»ã®ã¯ã¯ãã³ãè¬ã«ãmRNAã®æè¡ã䜿ãããŠããããšã«ãªããšæãã®ã§æ³šæãå¿
èŠããã®æè¡ã¯ãŸã äžå®èŠçŽ ãå€ããå®äŸ¡ã«æ©ã倧éã«äœæåºæ¥ãã®ã§è£œè¬äŒç€Ÿçã¯é£ã³ä»ãã ãããã
10/18(æ)
ãåµè¬ãã³ãã£ãŒã®VLPã»ã©ãã¥ãŒãã£ã¯ã¹ã»ãžã£ãã³ïŒæ±äº¬ïŒã¯18æ¥ãéçºãé²ããŠãã次äžä»£åã®æ°åã³ãããŠã€ã«ã¹ã¯ã¯ãã³ã«ã€ããŠãæ¥å¹Žäžã®å®çšåãç®æããšçºè¡šãããã
ãåµè¬ãã³ãã£ãŒã®VLPã»ã©ãã¥ãŒãã£ã¯ã¹ã»ãžã£ãã³ïŒæ±äº¬ïŒã¯18æ¥ãéçºãé²ããŠãã次äžä»£åã®æ°åã³ãããŠã€ã«ã¹ã¯ã¯ãã³ã«ã€ããŠãæ¥å¹Žäžã®å®çšåãç®æããšçºè¡šãããã
RNAãäœå
ã§èªå·±å¢æ®
èšã£ã¡ãã£ãŠãðš
èšã£ã¡ãã£ãŠãðš
ã€ã€ããŒïŒããŒãããããã©ããã
ïœïŒ²ïŒ®ïŒ¡ã¯ã¯ãã³ã®åŒ±ç¹ã¯å¹æã®æç¶æéãçããå¯äœçšã倧ããããš
VLPã»ã©ãã¥ãŒãã£ã¯ã¹ã»ãžã£ãã³ã®ãã®ã¯ããããæ¹åããããã
VLPã»ã©ãã¥ãŒãã£ã¯ã¹ã»ãžã£ãã³ã®ãã®ã¯ããããæ¹åããããã
次äžä»£ã¯ã¯ãã³ãæ¥å¹Žå®çšå æ°åã³ããã
ãã³ãã£ãŒéçº(æäºéä¿¡)
VLPã®ã¯ã¯ãã³ã¯ ãŠã€ã«ã¹ã®éºäŒæ å ±ãäŒãã
RNAãäœå ã§èªå·±å¢æ®ã å¹ççã«å ç«ãèªå°ãã
ãã¬ããªã³ã³ã¯ã¯ãã³ãæäžéãçŸåšã®mRNAã¯ã¯ãã³ã®10åã®1ãã100åã®1ã§æžããšããã
ãã³ãã£ãŒéçº(æäºéä¿¡)
VLPã®ã¯ã¯ãã³ã¯ ãŠã€ã«ã¹ã®éºäŒæ å ±ãäŒãã
RNAãäœå ã§èªå·±å¢æ®ã å¹ççã«å ç«ãèªå°ãã
ãã¬ããªã³ã³ã¯ã¯ãã³ãæäžéãçŸåšã®mRNAã¯ã¯ãã³ã®10åã®1ãã100åã®1ã§æžããšããã
ãšãŠãçŽ æŽãããäºã§æåŸ
ããããã
æ¥æ¬ã®ä»£è¡šè¬åã¯ã圱ã圢ãæ å ±ããªããç 究è ãæµ·å€æµåºããŠãããã ããã
æ¥æ¬ã®ä»£è¡šè¬åã¯ã圱ã圢ãæ å ±ããªããç 究è ãæµ·å€æµåºããŠãããã ããã
æ¥å¹Žå®çšåâŠæ²»éšã¹ãé£ã°ãæ°æºã
ãããããã
å幎ããšã«æ¥âããŠãæäœã調ã¹ãªãã¡ãããããããªã¢ãããïŒå¹ŽãïŒå¹Žã§æ²»éšãçµããã¯ããªãã ãã
æ¥å¹Žãšãèšã£ãŠãæç¹ã§è©æ¬ºç¢ºå®ã ãã
å幎ããšã«æ¥âããŠãæäœã調ã¹ãªãã¡ãããããããªã¢ãããïŒå¹ŽãïŒå¹Žã§æ²»éšãçµããã¯ããªãã ãã
æ¥å¹Žãšãèšã£ãŠãæç¹ã§è©æ¬ºç¢ºå®ã ãã
æ¯æŽéç®çã ãã§ã¯ãªãããšãç¥ãã
ãªãã ããã èšã£ãŠããåœç£ãäžçªå®å¿ã§ããã
#
#
( ïŸïŸÐïŸ)ãã¯ããããããŸããçŠå²¡ã¯âã§ããã³ããã¯ã¯ãã³ã®éçºãé²ãã§ããããã§ãããæ©ããã¹ã¯ãªãã®ç掻ã«æ»ãããã§ãããä»æ¥ãè¯ã1æ¥ã«ãªããŸãããã«ãÂ
æ¥æ¬ããã®ã³ããã¯ã¯ãã³äŸçµŠãåæããŠããŸããç¥ãåãïŒããäŒç€Ÿã®ç€Ÿé·ããïŒã§æ¥æ¬ã®ã¯ã¯ãã³ããæããªããšèšãããæ¹ã®ããããŸããã
å°å
ã§èšåºè©ŠéšãéããŠããçŽåœç£ã¯ã¯ãã³ãå¯åå¿ãé²éªšã«åºãæµ·å€è£œã¯ã¯ãã³ãããããã®ã¯ã¯ãã³ãç©æ¥µçã«æåãããããªããªãæ²»éšã«ãåå ããããªãã
éºäŒåãæäœããçºæ³ãªã©äººéã®å
ç«æ©èœãèããèãã ã
人é¡ãé·ã幎æãæããŠç¯ãäžããçŽ æŽãããèœåããæµ å¢ãªæèã§è¶ ããã€ããã«ã§ããªã£ãŠããã®ããªïŒ
人é¡ãé·ã幎æãæããŠç¯ãäžããçŽ æŽãããèœåããæµ å¢ãªæèã§è¶ ããã€ããã«ã§ããªã£ãŠããã®ããªïŒ
RNAã ããçæéã§å解ãã å®å
šå®å¿ãªããããªãã®ãïŒ ãªããé·æã®æ²»éšãå¿
èŠãªæããããã§ãã
å ±éã§ã¯å¹æãããè¬å®³ã®è»œæžãæåŸ
ãããŠããããã
ãããæ¥å¹Žå®çšåã«ãšèšãäºã
æ¥å¹Žã«ã¯èœã¡çãããæ¹åã§é²ãã§ããã¿ããããª
ãããæ¥å¹Žå®çšåã«ãšèšãäºã
æ¥å¹Žã«ã¯èœã¡çãããæ¹åã§é²ãã§ããã¿ããããª
çŸæç¹ã§ã³ãã¯ã¯æã£ãŠãªã人ã¯
ä»åŸããã©ããªã¯ã¯ãã³ãåºãŠããŠã
æããªããšæããã©ã
æ¢ã«ã³ãã¯ã¯æã£ã人ã®äžãã
ãåžæè ããåã£ãŠæã€ã®ããªð
ä»åŸããã©ããªã¯ã¯ãã³ãåºãŠããŠã
æããªããšæããã©ã
æ¢ã«ã³ãã¯ã¯æã£ã人ã®äžãã
ãåžæè ããåã£ãŠæã€ã®ããªð
ããïŒå€§éªã¯ã¯ãã³ãšãã©ãè¡ã£ãïŒ
ãããçšé䜿ã£ãŠãããïŒ
ããŒãåæïŒ
倧éªã¯ã¯ãã³æšå¹Žäžã«å®çšåå®çŸãããŸãèšããŠãããïŒã©ããªã£ãŠãïŒæããžããã©ãåã¯ã¢ã«ã³ã§åæ
åã€ããäºã«è¬çœªãäœããªã
ãããçšé䜿ã£ãŠãããïŒ
ããŒãåæïŒ
倧éªã¯ã¯ãã³æšå¹Žäžã«å®çšåå®çŸãããŸãèšããŠãããïŒã©ããªã£ãŠãïŒæããžããã©ãåã¯ã¢ã«ã³ã§åæ
åã€ããäºã«è¬çœªãäœããªã
ã¬ããããªã³ã³ãã
VLPã®ã¯ã¯ãã³ã¯ããŠã€ã«ã¹ã®éºäŒæ
å ±ãäŒããRNAãäœå
ã§èªå·±å¢æ®ããå¹ççã«å
ç«ãèªå°ãããã¬ããªã³ã³ã¯ã¯ãã³ããæäžéãçŸåšã®mRNAã¯ã¯ãã³ã®10åã®1ãã100åã®1ã§æžããšããã
ãŸãæ¿åºã®å©æš©ã絡ãã®äºããïŒïŒ
ã¬ããªã³ã³ã¯ã¯ãã³ããDNAãä»ããã«RNAã®ã¿ã§å¢æ®ããä»çµã¿ãããããã ããããã¯ç¥ããªãã£ãã
補é åèšã¯å¯å£«ãã€ã«ã ããŒã«ãã£ã³ã°ã¹
ãªãããè¡æ£èãæãã¡ããã®ã¯äœæ
ïŒ
ãæ¥å¹Žå®çšå æ°åã³ããããã³ãã£ãŒéçº
ã次äžä»£ã¯ã¯ãã³22幎å®çšåãç®æ⊠ã»ãžã£ãã³ã¯18æ¥ãéçºãé²ããŠãã次äžä»£åã®æ°åã³ãããŠã€ã«ã¹ã¯ã¯ãã³ã«ã€ããŠãNPBãžæèŠæžãæåºããããçå£ã«èŠæããããšãæãããã
ãã¡ã§ãæãåºã
2019幎ãŸã§
ã¯ã¯ãã³ãã«ãã³"(ïŸ*>â<)ïŸã£ãŠ
åãã§ããã€ãããïŒ
ãã®ç¶æ³ã
ç°åžžã ãšæããªããã€ããããªã
ããã€ãç°åžžã
ã¯ã¯ãã³ã¯è©æžããïŒ
ãããšãè³æ ŒãïŒ
2019幎ãŸã§
ã¯ã¯ãã³ãã«ãã³"(ïŸ*>â<)ïŸã£ãŠ
åãã§ããã€ãããïŒ
ãã®ç¶æ³ã
ç°åžžã ãšæããªããã€ããããªã
ããã€ãç°åžžã
ã¯ã¯ãã³ã¯è©æžããïŒ
ãããšãè³æ ŒãïŒ
å売ã§æ¥å¹Žãç
œãããã£ãŠäºã
æ¥å¹Žããã¯ã£ãŠä»å¹Žèªç²ãã¡ãã£ãéµåã¿æŽŸã¯
åŠäœããïŒãã®åã«æ¬¡ã®æ³¢ã¯åŠäœããïŒ
ãŸã éµåã¿ã§å¥œã鎚ãç¶ããã®ïŒ
æ¥å¹Žããã¯ã£ãŠä»å¹Žèªç²ãã¡ãã£ãéµåã¿æŽŸã¯
åŠäœããïŒãã®åã«æ¬¡ã®æ³¢ã¯åŠäœããïŒ
ãŸã éµåã¿ã§å¥œã鎚ãç¶ããã®ïŒ
ããã¯ã³ãã察çã ãã§ãªããæ¥æ¬çµæžã®æªæ¥ã«ãšã£ãŠããšãŠã倧äºãªè©±ã ãšçé¢ç®ã«æãã
çæéã§å€§éäŸçµŠãå¯èœãªæ¬¡äžä»£ã¯ã¯ãã³ã®æ²»éšãéå§ãããŸããã2022幎äžã®è¬äºæ¿èªç³è«ãšå®çšåãç®æããŠããŸãã
æ¬åœããªïŒ
å¯åå¿ãå°ãªãããããð¶
ããçµæãåºããšãããªããð
ããçµæãåºããšãããªããð
ãŸãæ°ããã®æ¥ã¡ãã£ãã
ããèªå·±å¢æ®ããã®ãã¡ãã£ãšæããããã¡ãããšäžå®æéã§åæ¢ããã®ããªãâŠã
4901 å¯å£«ãã€ã«ã HD è²·ã£ãŠããã«è¯ããã¥ãŒã¹ æåãç¥ã â
補é ã¯å¯å£«ãã€ã«ã ãæ
ããæ倧幎5000äžååã®çç£ãåœé¢ã®ç®æš
åœå
ãã³ãã£ãŒã®VLPã»ã©ãã¥ãŒãã£ã¯ã¹ãã¬ããªã³ã³RNAã䜿ãæ°åã³ããã¯ã¯ãã³ããæ°æè¡ã»æ¬¡äžä»£åããšããŠå£²ãåºããŠããããã§ãããã¬ããªã³ã³RNAã¯ã¯ãã³ãªãPfizer-BioNTechãæ¢ã«èšåºè©Šéšã§è©ŠããŠãããã§ããããBNT162c2ãšããéçºã³ãŒãã§ããã
ãŒãŒãŒ æåŸ
ããŠããŸãã
ã補é ã¯å¯å£«ãã€ã«ã ãæ
ããæ倧幎5000äžååã®çç£ãåœé¢ã®ç®æšãšããã
ã¬ããªã³ã³ã¯ã¯ãã³ã®éçºã¯æ¿åºãè³éæ¯æŽããŠãããã
ã¬ããªã³ã³ã¯ã¯ãã³ã®éçºã¯æ¿åºãè³éæ¯æŽããŠãããã
ã¬ããªã³ã³ã¯ã¯ãã³ã¯ç±³åœãªã©ã§æ²»éšãå§ãŸã£ãŠããŸãããåœå
ã§ã¯åããŠã§ãã
现èå
ã§èªå·±å¢æ®?
æãåå¢âŠðš
ã
æãåå¢âŠðš
ã
次äžä»£ã¯ã¯ãã³æ
å ±